Versailles Healthcare LLC

NeurAxis is a pioneer in neuromodulation therapies aimed at treating chronic and debilitating conditions, particularly focusing on disorders related to gut-brain interactions in pediatric and adolescent populations. Their innovative device, IB-Stim, is FDA cleared and designed to alleviate functional abdominal pain associated with irritable bowel syndrome and functional dyspepsia without the need for drugs or surgery. The company's mission emphasizes improving lives and minimizing suffering, especially among children and adolescents suffering from gastrointestinal issues. By continually evolving their approaches and solutions, NeurAxis seeks to address unmet healthcare needs and enhance patient outcomes in the realm of chronic pain management. Generated from the website

NeurAxis is a pioneering company focused on neuromodulation therapies, specifically targeting chronic and debilitating conditions, particularly those affecting the pediatric and adolescent populations suffering from disorders of gut-brain interactions. Their innovative product, IB-Stim, is the first FDA-cleared drug-free and non-surgical device designed to alleviate functional abdominal pain associated with irritable bowel syndrome in young patients aged 8-21. The company's mission centers on improving lives and minimizing suffering, particularly within the pediatric demographic. Through ongoing research and development, NeurAxis aims to enhance patient outcomes and address the unmet healthcare needs of adults experiencing gastrointestinal issues as well. Generated from the website